X
API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.biospace.com/article/releases/mirum-announces-label-expansion-for-livmarli-in-the-united-states-to-include-infants-three-months-of-age-and-older/
https://www.biospace.com/article/mirum-scores-unprecedented-phase-iii-win-in-rare-liver-disorder/
https://www.businesswire.com/news/home/20221005005359/en/Mirum-Pharmaceuticals-to-Present-LIVMARLI%C2%AE-maralixibat-Analyses-and-Host-a-Scientific-Symposium-at-NASPGHAN-2022-Annual-Meeting
https://www.biospace.com/article/releases/first-patient-dosed-in-can108-maralixibat-embark-phase-2-study-in-biliary-atresia-in-china/
https://ir.mirumpharma.com/news-releases/news-release-details/mirum-pharmaceuticals-present-livmarlitm-maralixibat-analyses
https://www.businesswire.com/news/home/20211115006047/en/Six-Year-Natural-History-Comparison-with-Mirum%E2%80%99s-LIVMARLI-maralixibat-Demonstrates-Event-Free-Survival-and-Transplant-Free-Survival-in-Patients-with-Alagille-Syndrome
https://endpts.com/fda-approves-mirum-pharmas-first-treatment-for-rare-pediatric-bile-duct-disease/
https://www.biospace.com/article/fda-action-alert-mirum-and-kite-gilead/?s=71
https://endpts.com/takeda-snaps-up-the-japanese-rights-to-an-old-shire-cast-off-boehringer-ingelheim-acquires-abexxa-biologics/
https://www.businesswire.com/news/home/20210616005316/en/Mirum-Pharmaceuticals-to-Showcase-Analyses-From-Its-Rare-Liver-Disease-Programs-at-The-International-Liver-Congress-2021
https://ir.mirumpharma.com/news-releases/news-release-details/mirum-pharmaceuticals-broadens-expanded-access-program
https://in.news.yahoo.com/mirum-pharmaceuticals-present-maralixibat-data-123000131.html
https://www.biospace.com/article/mirum-preps-rolling-nda-for-algs-candidate-maralixibat
https://news.yahoo.com/mirum-maralixibat-demonstrates-transplant-free-123000801.html
https://endpts.com/in-86m-ipo-pitch-mirum-spells-out-plans-to-turn-shire-discards-into-orphan-liver-drug-successes/
https://www.prnewswire.com/news-releases/mirum-pharmaceuticals-secures-120-million-in-series-a-financing-to-develop-phase-3-ready-maralixibat-for-rare-liver-diseases-300745243.html
https://www.fiercebiotech.com/biotech/mirum-scoops-120m-to-take-ex-shire-drug-into-phase-3
Market Place
Share 
